Retatrutide remains in clinical development and is not approved for general prescribing or self-administration in the UK
Peptide mass: 10mg Bacteriostatic water: 2mL Concentration: 10mg 2mL = 5 mg/mL = 5,000 mcg/mL Peptide per unit (100-unit syringe): 5 mg 100 = 0.05 mg/unit = 50 mcg/unit If research protocol calls for 250 mcg per research unit: 250 mcg 50 mcg/unit = 5 units on the syringe Total doses per vial at 250 mcg each: 10,000 mcg 250 mcg = 40 research doses That single 10mg vial, reconstituted with 2mL of bacteriostatic water, provides 40 research doses of 250 mcg each, drawn to the 5-unit mark on a standard insulin syringe
Explore insights, tips, and product recommendations on cosmeceuticals, advanced treatments, RX skincare, and cosmetology
Both peptides have extensive, independent published research bases spanning pre-clinical models, mechanism studies, and clinical investigations
A search on PubMed returns many papers on rodents and cell models, and reviews on PubMed Central describe it as a possible therapy rather than a proven one
a separate Limulus amebocyte lysate (LAL) or recombinant factor C test is required, and most commodity vendors do not publish this data